Last week Neola Medical released the Q3 report for 2023. In connection, CEO Hanna Sjöström and CFO Christian Gyllenberg presented the report in a videoconference. Apart from presenting the company’s financials and the significant events from this quarter, they also tell more about the new strong clinical results from independent research, the latest from the launchwork in the U.S. and upcoming studies. After the presentation, the questions that came in were answered in a shorter Q&A session.

The presentation was recorded and can be found here: